grant

Age-related mechanisms of T helper 2 memory in the early lung

Organization MASSACHUSETTS GENERAL HOSPITALLocation BOSTON, UNITED STATESPosted 9 Jul 2021Deadline 30 Jun 2026
NIHUS FederalResearch GrantFY202421+ years oldAddressAdeno-Associated VirusesAdoptive TransferAdrenergic AgentsAdrenergic DrugsAdrenergicsAdultAdult HumanAgeAge of OnsetAirway DiseaseAllergensAllergic asthmaAllergic inflammationAlpha Interleukin 2 ReceptorAssayAsthma in ChildrenBDNFBasal Transcription FactorBasal transcription factor genesBioassayBiological AssayBirthBrain-Derived Neurotrophic FactorBronchial ConstrictionBronchoconstrictionCD4 CellsCD4 Positive T LymphocytesCD4 T cellsCD4 helper T cellCD4 lymphocyteCD4+ T-LymphocyteCD4-Positive LymphocytesCell BodyCell Communication and SignalingCell SignalingCellsChildhood AsthmaClinical ResearchClinical StudyCo-StimulatorCommunicationComplexCostimulatorD4DRDRD4DRD4 geneDependoparvovirusDependovirusDopamineDopamine Receptor D4EnvironmentEpidermal Thymocyte Activating FactorEpigeneticEpigenetic ChangeEpigenetic MechanismEpigenetic ProcessExtrinsic asthmaFosteringGWA studyGWASGene DeliveryGene TranscriptionGeneral Transcription Factor GeneGeneral Transcription FactorsGenetic TranscriptionHistologicHistologicallyHumanHydroxytyramineIL-2IL-2RalphaIL-2RαIL2 ProteinInflammationInterleukin 2Interleukin 2 PrecursorInterleukin IIInterleukin-2Interleukine 2Interleukine 2 PrecursorInterleukine IIInterventionIntervention StrategiesIntracellular Communication and SignalingLifeLinkLocationLong-Term EffectsLongterm EffectsLow Affinity Interleukin 2 ReceptorLungLung Respiratory SystemLymphocyte Mitogenic FactorMGF proteinMGSNF proteinMapsMediatingMediatorMemoryMitogenic FactorModern ManMolecular TargetNeonatalNerveNerve CellsNerve Growth FactorsNerve UnitNeural CellNeurocyteNeuronotrophic FactorsNeuronsNeurotrophic ProteinsOvalbuminParturitionPathogenesisPathway interactionsPatientsPediatric asthmaPharmaceutical AgentPharmaceuticalsPharmacologic SubstancePharmacological SubstancePhenotypePolycombPredispositionPublishingRNA ExpressionReceptor ProteinRecurrenceRecurrentRecurrent diseaseRelapsed DiseaseReportingRiskRoleSTAT5STAT5ASTAT5A geneSTAT5a Transcription FactorSeveritiesSignal Transducer and Activator of Transcription 5ASignal TransductionSignal Transduction SystemsSignalingStat5 proteinStat5a proteinStat5alpha proteinSusceptibilityT cell growth factorT-Cell Growth FactorT-Cell Stimulating FactorT-CellsT-LymphocyteT4 CellsT4 LymphocytesTestingThymocyte Stimulating FactorTranscriptionTranscription Factor Proto-OncogeneTranscription factor genesViraladeno associated virus groupadulthoodage associatedage correlatedage dependentage linkedage relatedage specificagesairway epithelium inflammationairway inflammationallergen responseallergic responseallergy responsealpha-subunit, receptor, interleukin-2asthmaticatopic asthmabiological signal transductioncandidate identificationchronic airway diseasechronic inflammatory diseasechronic respiratory diseaseearly childhoodearly life exposureempowermentepigeneticallyextrinsic allergic asthmagene signaturesgenetic approachgenetic signaturegenetic strategygenome wide associationgenome wide association scangenome wide association studiesgenome wide association studygenomewide association scangenomewide association studiesgenomewide association studyin vivoinfancyinfantileinnervationinsightinterleukin-2Ralphainterventional strategylung developmentmammary gland factormammary gland-specific nuclear factormouse modelmurine modelneonatal exposureneonatenerve supplyneuronalnew drug treatmentsnew drugsnew pharmacological therapeuticnew therapeuticsnew therapynext generation therapeuticsnovelnovel drug treatmentsnovel drugsnovel pharmaco-therapeuticnovel pharmacological therapeuticnovel therapeuticsnovel therapyoverexpressoverexpressionpathwaypharmaceuticalpost-natal developmentpostnatalpostnatal developmentpulmonaryreceptorrespiratory inflammationrespiratory tract inflammationsignal tranducer and activator of transcription 5social rolethymus derived lymphocytetranscription factortranscriptome profilingtranscriptomic profilingtranscriptomicstreatment strategywhole genome association analysiswhole genome association studieswhole genome association study
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

PROJECT SUMMARY
Allergic asthma is one of the most common, chronic airway diseases that often progresses from infancy and

early childhood into adulthood. Current therapies are directed at antagonizing inflammation and bronchial

constriction. Despite their widespread use, these therapies have no beneficial effect on slowing down the

progression of allergic asthma. The central mediator of anamnestic allergic responses is allergen-specific, T

helper 2 resident memory cells (Th2-TRMs). As such, targeting the establishment of allergen-specific, Th2-TRMs

following early life exposure provides an opportunity to modulate and impede progressive allergic asthma.

However, how Th2-TRMs are established in the early lung has never been studied. To address this critical issue

in the pathogenesis of progressive allergic asthma, we have investigated the causal link between allergen

exposure in early life and the long-term effect on airway inflammation. Our study focuses on the communication

between sympathetic nerves and CD4+ T cells in the postnatal, developing lung. So far, our published and

preliminary studies have identified a significant role of nerve-derived dopamine in susceptibility to allergic asthma

in early life and anamnestic allergic responses in adults. We show that dopamine signals through a T cell-specific

DRD4 receptor to promote Th2-TRM phenotypes by activating transcriptional factors and epigenetic modulators

in Th2 cells. Interestingly, sympathetic nerves transition into an adrenergic phenotype with age. Therefore, nerve-

derived dopamine operates in an age-related manner to promote Th2 memory. Given the critical role of dopamine

in the establishment of Th2-TRMs in the early lung, we have investigated the postnatal development of

sympathetic nerves. We found an age-related reduction in the levels of nerve growth factor (NGF) and brain-

derived neurotrophic factor (BDNF) that was associated with the dopaminergic-to-adrenergic transition of

sympathetic nerves. Empowered by these preliminary findings, we propose the central hypotheses: dopamine

promotes the establishment of allergen-specific, Th2-TRMs in the early lung; the dopaminergic-to-

adrenergic transition of sympathetic nerves is caused by age-related reduction in NGF and BDNF levels.

These hypotheses will be tested by the following three specific aims. Aim 1 will define the specific role of

dopamine in the abundance and the function of allergen-specific, Th2-TRMs following allergen exposure in early

life. Aim 2 will identify functional mediators of dopamine signaling in Th2-TRM phenotypes. Aim 3 will determine

the role of NGF and BDNF in sympathetic innervation and allergen-specific, Th2-TRMs in the lung. Of note,

clinical studies and GWAS have reported positive correlation between the levels of NGF and BDNF and allergic

asthma. Taken together, our proposed studies will provide insights into the establishment of Th2-TRMs in the

early lung and identify molecular targets for the intervention of progressive asthma from childhood to adulthood.

Grant Number: 5R01HL154549-04
NIH Institute/Center: NIH

Principal Investigator: Xingbin Ai

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →